MMCAP International Inc. SPC Takes Position in Translational Development Acquisition Corp. (NASDAQ:TDACU)

MMCAP International Inc. SPC acquired a new stake in shares of Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 350,000 shares of the company’s stock, valued at approximately $6,454,000. Translational Development Acquisition comprises 1.0% of MMCAP International Inc. SPC’s holdings, making the stock its 27th largest position.

A number of other large investors have also made changes to their positions in TDACU. Tuttle Capital Management LLC bought a new stake in Translational Development Acquisition in the fourth quarter valued at about $461,000. Wolverine Asset Management LLC bought a new stake in Translational Development Acquisition in the fourth quarter valued at about $5,716,000. Finally, Calamos Advisors LLC bought a new stake in Translational Development Acquisition in the fourth quarter valued at about $6,915,000.

Translational Development Acquisition Trading Up 0.1 %

NASDAQ TDACU opened at $10.13 on Wednesday. The company has a 50-day simple moving average of $10.05. Translational Development Acquisition Corp. has a twelve month low of $10.00 and a twelve month high of $10.30.

About Translational Development Acquisition

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

Further Reading

Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report).

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.